Skip to main content
Log in

Plasma and cerebrospinal fluid concentrations of indomethacin in humans

Relationship to analgesic activity

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Plasma and cerebrospinal fluid (CSF) concentrations of indomethacin have been determined in 52 patients hospitalized for nerve-root compression pain. Samples of blood and CSF were collected at the same time in each subject, 0.5 to 12 h after a single intramuscular injection of 50 mg indomethacin. Analgesic effect was assessed by the absolute and percentage variation in Huskisson's visual analogue scale between dosing and sampling.

According to its high lipid solubility, indomethacin rapidly crossed the blood-brain barrier, being detected in CSF 0.5 h after administration. After attainment of equilibrium within 2 h, the CSF level exceeded the free plasma level. Since the drug was extensively bound to serum albumin (99.7±0.1%), this phenomenon may represent a slight degree of binding of indomethacin in CSF.

The analgesic activity was not related to either the plasma or CSF concentration of indomethacin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Ferreira SH, Lorenzetti BB, Corrêa FMA (1978) Central and peripheral antialgesic action of aspirin-like drugs. Eur J Pharmacol 53: 39–48

    Google Scholar 

  2. Astier A, Renat B (1982) Sensitive high-performance liquid chromatographic determination of indomethacin in human plasma. J Chromatogr 233: 279–288

    Google Scholar 

  3. Mehta AC, Calvert RT (1983) An improved high-performance liquid chromatographic procedure for monitoring indomethacin in neonates. Ther Drug Monitor 5: 143–145

    Google Scholar 

  4. Quiding H, Häggquist SO (1983) Visual analogue scale and the analysis of analgesic action, Eur J Clin Pharmacol 24: 475–478

    Google Scholar 

  5. Bannwarth B, Netter P, Pourel J, Royer RJ, Gaucher A (1989) Clinical pharmacokinetics of nonsteroidal anti-inflammatory drugs in the cerebrospinal fluid. Biomed Pharmacother 43: 121–126

    Google Scholar 

  6. Hucker HB, Zacchei AG, Cox SV, Brodie DA, Cantwell NHR (1966) Studies on the absorption, distribution and excretion of indomethacin in various species. J Pharmacol Exp Ther 153: 237–249

    Google Scholar 

  7. Rothermich NO (1971) The fate of rectally administered radioactive indomethacin in human subjects. A preliminary report. Clin Pharmacol Ther 12: 300–301

    Google Scholar 

  8. Sheiner LB (1984) The population approach to pharmacokinetic data analysis: rationale and standard data analysis method. Drug Metab Rev 15: 153–171

    Google Scholar 

  9. Fowler PD, Dawes PT (1985) Osmosin: its effect on plasma and synovial fluid kinetics of indomethacin. Eur J Clin Pharmacol 27: 689–691

    Google Scholar 

  10. Brune K, Lanz R (1985) Pharmacokinetics of non-steroidal anti-inflammatory drugs. In: Bonta IL, Bray MA, Parnham MJ (ed) The pharmacology of inflammation. Elsevier, Amsterdam (Handbook of Inflammation, vol 5)

    Google Scholar 

  11. Helleberg L (1981) Clinical pharmacokinetics of indomethacin. Clin Pharmacokinet 6: 245–258

    Google Scholar 

  12. Alvan G, Orme M, Bertillson L, Ekstrand R, Palmer L (1975) Pharmacokinetics of indomethacin. Clin Pharmacol Ther 18: 364–373

    Google Scholar 

  13. Netter P, Lapicque F, Bannwarth B, Tamisier JN, Thomas P, Royer RJ (1985) Diffusion of intramuscular ketoprofen into the cerebrospinal fluid. Eur J Clin Pharmacol 29: 319–321

    Google Scholar 

  14. Oldendorf WK (1974) Lipid solubility and drug penetration of the blood brain barrier. Proc Soc Exp Biol Med 147: 813–816

    Google Scholar 

  15. Bonati M, Kanto J, Tognoni G (1982) Clinical pharmacokinetics of cerebrospinal fluid. Clin Pharmacokinet 7: 312–335

    Google Scholar 

  16. Zecca L, Broggini M, Pirola R, Campi R, Ferrario P, Bichisao E, Maresca V (1988) The diffusion of pirprofen into the cerebrospinal fluid in man. Eur J Clin Pharmacol 35: 81–83

    Google Scholar 

  17. Bannwarth B, Netter P, Gaucher A, Royer RJ (1986) Delayed appearance of salicylate in cerebrospinal fluid. J Rheumatol 13: 993–994

    Google Scholar 

  18. Alfredsson G, Sedvall G (1980) Protein binding of chlorpromazine in cerebrospinal fluid and serum. Int Pharmacopsychiat 15: 261–269

    Google Scholar 

  19. Day RO, Graham GG, Williams KM, Champion GD, De Jager J (1987) Clinical pharmacology of non-steroidal anti-inflammatory drugs. Pharmacol Ther 33: 383–443

    Google Scholar 

  20. Meredith TJ, Vale JA (1986) Non-narcotic analgesics. Problems of overdosage. Drugs 32 [Suppl 4]: 177–205

    Google Scholar 

  21. Huskisson EC (1974) Measurement of pain. Lancet II: 1127–1131

    Google Scholar 

  22. Yaksh TL (1982) Central and peripheral mechanisms for the antialgesic action of acetylsalicylic acid. In: Barnett HJM, Hirsh J, Fraser Mustard J (eds) Acetylslicylic acid. New uses for an old drug. Raven Press, New York

    Google Scholar 

  23. Ferreira SH (1985) Prostaglandin hyperalgesia and the control of inflammatory pain. In: Bonta IL, Bray MA, Parnham MJ (ed) The pharmacology of inflammation. Elsevier, Amsterdam (Handbook of Inflammation, vol 5)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported by a grant from Merck-Sharp and Dohme Chibret France

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bannwarth, B., Netter, P., Lapicque, F. et al. Plasma and cerebrospinal fluid concentrations of indomethacin in humans. Eur J Clin Pharmacol 38, 343–346 (1990). https://doi.org/10.1007/BF00315572

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00315572

Key words

Navigation